weight watchers glp 1 reviews WeightWatchers' stock soars after adding compounded GLP-1 treatment to its offering Weight Watchers Releases GLP-1 Results
Description
Observational data from patients with type 2 diabetes and concurrent rheumatoid arthritis provide indirect evidence
Khan MS, Fonarow GC, McGuire DK, Hernandez AF, Vaduganathan M, Rosenstock J, et al
doi: 10.1016/j.ejcb.2017.03.004 [DOI] [PubMed] [Google Scholar] 185
45 Conclusion Individualising patient care is essential in the ongoing multifaceted management of diabetes
These results support the continued safe use of GLP-1 RAs in T2DM and obesity, although longer trials with cancer-specific endpoints are warranted
